Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure

Background/Aims: Studies on elective switching to the subcutaneous (SC) formulation of infliximab revealed comparable efficacy and safety and higher infliximab level than those exhibited by intravenous (IV) infliximab. However, no studies have reported on the effectiveness of SC switching in ulcerat...

Descrición completa

Detalles Bibliográficos

Principais autores:	June Hwa Bae, Jung-Bin Park, Ji Eun Baek, Seung Wook Hong, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sung Wook Hwang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Gastroenterology Council for Gut and Liver 2024-07-01
Series:	Gut and Liver
Assuntos:	ulcerative colitis; infliximab; subcutaneous
Acceso en liña:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl230291
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!